查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575025

癌症診斷市場中的人工智慧，按疾病類型、成分、最終用戶、國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

AI in Cancer Diagnostics Market, By Disease Type, By Component, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，癌症診斷中的人工智慧市場規模為9.0198億美元，2024年至2032年的複合年成長率為9.40%。

癌症診斷市場中的人工智慧-市場動態

新藥組合的不斷開發以及對標靶和免疫療法的需求不斷成長預計將推動市場需求

人工智慧（AI）已成為癌症診斷領域的變革力量，顯著增強了檢測和分類各種類型癌症的能力，促進了市場成長。人工智慧可以分析成像模式，以確定癌症的類型和階段，以及可能影響治療選擇的其他特徵。它還評估組織樣本，識別異常細胞並量化腫瘤特徵，這對於診斷至關重要。人工智慧演算法可以處理大型基因組資訊資料集，以識別與特定癌症相關的突變，從而有助於個人化醫療。因此，對基因組資料不斷成長的需求有助於人工智慧在癌症診斷中的廣泛採用。

此外，人工智慧驅動的臨床決策支援系統（CDSS）有助於整合患者資料和臨床指南，以提出最有效和最新的治療計劃。 NLP 工具可以透過提供相關文獻或先前病例摘要來幫助臨床醫生為治療決策提供資訊。因此，人工智慧正在徹底改變癌症診斷的格局，實現更早的檢測、更準確的診斷和個人化的治療策略。隨著技術和方法的不斷進步，腫瘤學家、研究人員和資料科學家之間的合作對於充分發揮人工智慧在腫瘤學領域的潛力至關重要。

癌症診斷市場中的人工智慧 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 9.40% 左右的複合年成長率成長

根據疾病類型細分，由於大量飲酒和吸煙會引發癌症，預計其他細分市場將在 2023 年顯示最大的市場佔有率。

根據組件細分，由於軟體解決方案在醫療領域的快速採用，軟體細分市場將在 2023 年成為領先的組件細分市場。

根據最終用戶細分，由於癌症盛行率不斷上升，醫院細分市場將在 2023 年成為領先的最終用戶細分市場。

從地區來看，由於人工智慧技術在醫療保健產業的採用，北美在 2023 年成為領先的收入來源。

癌症診斷市場中的人工智慧—細分分析：

全球癌症診斷市場中的人工智慧會根據疾病類型、成分、最終用戶和地區進行細分。

依疾病類型，市場分為五類：乳癌、肺癌、攝護腺癌、腦腫瘤等。其他細分市場主導市場。菸酒消費的增加主要推動了細分市場的成長。

市場依組件分為三類：軟體、硬體和服務。軟體部分在市場上佔據主導地位。雲端系統和物聯網支援的人工智慧服務的日益普及正在推動細分市場的需求。

根據最終用戶，市場分為三類：醫院、外科中心等。醫院領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。醫院工作流程和平台中擴大採用人工智慧驅動的解決方案，補充了市場的成長。

癌症診斷市場中的人工智慧 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。由於先進的醫療基礎設施、強大的研發能力，北美成為最大的區域市場。由於受癌症影響的人口基數龐大且醫療保健投資不斷成長，預計亞太地區在預測期內將經歷最高的年複合成長率(CAGR)。歐洲是另一個重要市場，其推動因素包括先進人工智慧技術的採用、對研究的高度重視以及癌症的高盛行率。

癌症診斷市場中的人工智慧—競爭格局：

癌症診斷市場中人工智慧 (AI) 的競爭格局是由幾家知名公司以及技術進步和戰略合作夥伴關係的快速發展所決定的。市場的主要參與者包括成熟的醫療保健技術公司以及專注於專業人工智慧解決方案的創新新創公司。市場參與者正在強調開發能夠在早期階段高精度檢測癌症的人工智慧解決方案。這包括 MRI、CT 掃描和數位病理學等影像方式的進步。

2023 年，NVIDIA 與美敦力 (Medtronic) 合作，將 AI 技術整合到美敦力 (Medtronic) 的 GI Genius 智慧內視鏡模組中，增強對可能發展為癌症的結直腸息肉的早期檢測。

2023年，梅奧診所和Numares Health擴大了合作，開發基於人工智慧的慢性病診斷測試，這也可以增強癌症診斷能力。

2022 年 3 月，微軟收購了環境智慧與對話式 AI 領域的領導者 Nuance Communications。

目錄

第 1 章：癌症診斷市場中的人工智慧概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 人工智慧在癌症診斷市場中的疾病類型片段
    • 人工智慧在癌症診斷市場中的組成部分片段
    • 人工智慧在癌症診斷市場的最終用戶片段
    • 人工智慧在癌症診斷市場的國家片段
    • 癌症診斷中的人工智慧市場片段（按地區）
  • 競爭洞察

第 3 章：人工智慧在癌症診斷的主要市場趨勢

  • 癌症診斷市場促進因素中的人工智慧
    • 市場促進因素的影響分析
  • 人工智慧在癌症診斷市場的限制
    • 市場限制影響分析
  • 人工智慧在癌症診斷市場機會
  • 人工智慧在癌症診斷市場的未來趨勢

第 4 章：癌症診斷產業中的人工智慧研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：癌症診斷市場中的人工智慧：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：癌症診斷市場格局中的人工智慧

  • 2023 年癌症診斷中的人工智慧市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：癌症診斷市場中的人工智慧 - 按疾病類型

  • 概述
    • 按疾病類型分類的細分市場佔有率分析
    • 乳癌
    • 肺癌
    • 攝護腺癌
    • 腦腫瘤
    • 其他

第 8 章：癌症診斷市場中的人工智慧 - 按組成部分

  • 概述
    • 按組成部分分類的細分市場佔有率分析
    • 軟體
    • 硬體
    • 服務

第 9 章：癌症診斷市場中的人工智慧 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 手術中心
    • 其他

第 10 章：癌症診斷市場中的人工智慧 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 癌症診斷中的人工智慧北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按疾病類型）
    • 北美市場規模和預測（按組成部分）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲癌症診斷中的人工智慧主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按疾病類型）
    • 歐洲市場規模和預測（按組成部分）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 人工智慧在癌症診斷的應用 亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按疾病類型）
    • 亞太地區市場規模和預測（按組成部分）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症診斷中的人工智慧主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疾病類型）
    • 拉丁美洲市場規模和預測（按組成部分）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 人工智慧在癌症診斷中的應用中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疾病類型）
    • 中東和非洲市場規模及預測（按組成部分）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 癌症診斷產業中的人工智慧

  • 競爭儀表板
  • 公司簡介
    • EarlySign
    • Cancer Center.ai
    • Microsoft
    • Flatiron
    • Path AI
    • Therapixel
    • Tempus
    • Paige AI, Inc.
    • Maxwell Plus
    • Kheiron Medical Technologies Limited
    • SkinVision
    • Cancer Diagnostics Inc.
    • Siemens Healthineers
    • GE Healthcare
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4018

REPORT HIGHLIGHT

AI in Cancer Diagnostics Market size was valued at USD 901.98 Million in 2023, expanding at a CAGR of 9.40% from 2024 to 2032.

Combination therapy drug treatment refers to the use of two or more medications simultaneously to treat a disease or medical condition. This approach is commonly used in various fields of medicine to enhance treatment efficacy, reduce the risk of resistance, and target multiple aspects of a disease or condition. The drugs used in combination therapies can act through different mechanisms or at different stages of disease progression, providing a synergistic effect that single-drug treatments may not achieve.

AI in Cancer Diagnostics Market- Market Dynamics

Increasing development of new drug combinations and rising demand for targeted & immunotherapies is expected to propel market demand

Artificial Intelligence (AI) has emerged as a transformative force in the field of cancer diagnostics, significantly enhancing the ability to detect and classify various types of cancer, boosting market growth. AI can analyze imaging patterns to determine the type and stage of cancer, as well as other characteristics that may influence treatment options. It also evaluates tissue samples, identifying abnormal cells and quantifying tumor characteristics, which is essential for diagnoses. AI algorithms can process large datasets of genomic information to identify mutations associated with specific cancers, aiding in personalized medicine. Thus, growing demand for genomic data is contributing to high adoption of AI in cancer diagnostics.

Further, AI powered Clinical Decision Support System (CDSS) helps integrate patient data and clinical guidelines to suggest the most effective and up-to-date treatment plans. NLP tools can aid clinicians by providing relevant literature or previous case summaries to inform treatment decisions. Thus, AI is revolutionizing the landscape of cancer diagnostics, enabling earlier detection, more accurate diagnoses, and personalized treatment strategies. As technology and methodologies continue to advance, collaboration among oncologists, researchers, and data scientists will be crucial for harnessing the full potential of AI in oncology.

AI in Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.40% over the forecast period (2024-2032)

Based on Disease Type segmentation, the others segment was predicted to show maximum market share in the year 2023, owing to high consumption of alcohol & tobacco inviting cancer diseases.

Based on Component segmentation, software segment was the leading Component segment in 2023, due to the rapid adoption of software solution in medical sector.

Based on End User segmentation, hospitals segment was the leading End User segment in 2023, due to increasing prevalence of cancer.

On the basis of region, North America was the leading revenue generator in 2023, due to the adoption of AI technologies in healthcare industry.

AI in Cancer Diagnostics Market- Segmentation Analysis:

Global AI in Cancer Diagnostics Market is segmented on the basis of Disease Type, Component, End User, and Region.

The market is divided into five categories based on Disease Type: breast cancer, lung cancer, prostate cancer, brain tumor, and others. The others segment dominates the market. The increasing consumption of tobacco & alcohol is mainly boosting segment growth.

The market is divided into three categories based on Component: software, hardware, and services. The software segment dominates the market. The increasing adoption of cloud systems and IoT enabled AI services are boosting segment demand.

The market is divided into three categories based on End User: hospitals, surgical centers, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising utilization of AI powered solutions into the workflows & platforms of hospital is supplementing market growth.

AI in Cancer Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is the largest regional market due to advanced healthcare infrastructure, strong research and development capabilities. Asia-Pacific is anticipated to experience the highest compound annual growth rate (CAGR) over the forecast period due to a large cancer-affected population base and growing healthcare investments. Europe is another significant market, driven by the adoption of advanced AI technologies, a strong focus on research, and a high prevalence of cancer.

AI in Cancer Diagnostics Market- Competitive Landscape:

The competitive landscape of Artificial Intelligence (AI) in the cancer diagnostics market is shaped by several prominent companies and the rapid pace of technological advancements and strategic partnerships. Key players in the market include well-established healthcare technology companies as well as innovative startups focusing on specialized AI solutions. Market players are emphasizing developing AI solutions that can detect cancer at an early stage with high precision. This includes advancements in imaging modalities like MRI, CT scans, and digital pathology.

In 2023, NVIDIA and Medtronic collaborated to integrate AI technology in Medtronic's GI Genius intelligent endoscopy module, enhancing early detection of colorectal polyps that could develop into cancer.

In 2023, Mayo Clinic and Numares Health expanded their collaboration to develop AI-based diagnostic tests for chronic diseases, which can also enhance cancer diagnostic capabilities.

In March 2022, Microsoft acquired Nuance Communications, a leader in ambient intelligence and conversational AI.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN CANCER DIAGNOSTICS MARKET KEY PLAYERS

  • EarlySign
  • Cancer Center.ai
  • Microsoft
  • Flatiron
  • Path AI
  • Therapixel
  • Tempus
  • Paige AI, Inc.
  • Maxwell Plus
  • Kheiron Medical Technologies Limited
  • SkinVision
  • Cancer Diagnostics Inc.
  • Siemens Healthineers
  • GE Healthcare
  • Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Breast cancer
  • Lung cancer
  • Prostate cancer
  • Brain tumor
  • Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019-2032

  • Software
  • Hardware
  • Services

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Surgical Centers
  • Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI in Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI in Cancer Diagnostics Market Snippet by Disease Type
    • 2.1.2. AI in Cancer Diagnostics Market Snippet by Component
    • 2.1.3. AI in Cancer Diagnostics Market Snippet by End User
    • 2.1.4. AI in Cancer Diagnostics Market Snippet by Country
    • 2.1.5. AI in Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. AI in Cancer Diagnostics Key Market Trends

  • 3.1. AI in Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI in Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI in Cancer Diagnostics Market Opportunities
  • 3.4. AI in Cancer Diagnostics Market Future Trends

4. AI in Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI in Cancer Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI in Cancer Diagnostics Market Landscape

  • 6.1. AI in Cancer Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI in Cancer Diagnostics Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 7.1.2. Breast cancer
    • 7.1.3. Lung cancer
    • 7.1.4. Prostate cancer
    • 7.1.5. Brain tumor
    • 7.1.6. Others

8. AI in Cancer Diagnostics Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 8.1.2. Software
    • 8.1.3. Hardware
    • 8.1.4. Services

9. AI in Cancer Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Surgical Centers
    • 9.1.4. Others

10. AI in Cancer Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. AI in Cancer Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. AI in Cancer Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. AI in Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. AI in Cancer Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. AI in Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- AI in Cancer Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. EarlySign
    • 11.2.2. Cancer Center.ai
    • 11.2.3. Microsoft
    • 11.2.4. Flatiron
    • 11.2.5. Path AI
    • 11.2.6. Therapixel
    • 11.2.7. Tempus
    • 11.2.8. Paige AI, Inc.
    • 11.2.9. Maxwell Plus
    • 11.2.10. Kheiron Medical Technologies Limited
    • 11.2.11. SkinVision
    • 11.2.12. Cancer Diagnostics Inc.
    • 11.2.13. Siemens Healthineers
    • 11.2.14. GE Healthcare
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us